Clinical Trial Update: Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluates adjuvant docetaxel and cisplatin in patients with stage I-III non-small cell lung cancer completely removed by surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED